Tumor testing can lead to different treatment choices and better outcomes.
Testing all cases of colon cancer for the presence of microsatellite instability (MSI) is currently a national and international goal, said Thomas K. Weber, M.D., FACS, president of the Colon Cancer Foundation.
Testing patients for biomarkers such as MSI status and Lynch syndrome can have treatment implications that ultimately lead to improved outcomes
Music: Bensound
The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer
February 16th 2023Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Listen
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Listen